Chemed Corporation (CHE)

Revenue

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
VITAS Revenue	1.63B	1.53B
VITAS Revenue Growth	6.47%	16.42%
Roto-Rooter Revenue	899.88M	900.31M
Roto-Rooter Revenue Growth	-0.05%	-5.17%
Revenue (Total)	2.53B	2.43B
Revenue (Total) Growth	4.06%	7.37%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
VITAS Income From Operations	246.94M	263.97M
VITAS Income From Operations Growth	-6.45%	43.39%
Roto-Rooter Income From Operations	160.83M	194.52M
Roto-Rooter Income From Operations Growth	-17.32%	-14.22%
Corporate Income From Operations	-69.52M	-91.99M
Operating Income (Total)	338.25M	366.49M
Operating Income (Total) Growth	-7.71%	7.61%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
VITAS Adjusted EBITDA	271.91M	285.54M
VITAS Adjusted EBITDA Growth	-4.77%	39.70%
Roto-Rooter Adjusted EBITDA	204.73M	237.09M
Roto-Rooter Adjusted EBITDA Growth	-13.65%	-12.05%
Corporate Adjusted EBITDA	-17.93M	-19.62M
Operating Income (Other)	-120.46M	-136.51M
Operating Income (Total)	338.25M	366.49M
Operating Income (Total) Growth	-7.71%	7.61%

Net Income

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
VITAS Net Income	204.01M	216.82M
VITAS Net Income Growth	-5.91%	36.79%
Roto-Rooter Net Income	135.49M	160.05M
Roto-Rooter Net Income Growth	-15.34%	-14.98%
Corporate Net Income	-74.26M	-74.87M

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Total Average Daily Census (ADC) (Days)	22.34K	21.17K
Total Average Daily Census (ADC) (Days) Growth	5.51%	13.74%
Total Admissions	70.82K	67.45K
Total Admissions Growth	5.00%	6.33%
Total Discharges	70.53K	64.62K
Total Discharges Growth	9.15%	5.51%
Average Length of Stay (Days)	120.20	103.00
Average Length of Stay (Days) Growth	16.70%	0.78%
Median Length of Stay (Days)	18.00	17.00
Median Length of Stay (Days) Growth	5.88%	6.25%

Updated Dec 31, 2025. Data Source: Fiscal.ai.